Numinus has received amendments to its federal licence to allow the possession, production, assembly, sale, export, and delivery of a range of psychedelics including ketamine and LSD. This development expands the work that Numinus can conduct, including the possibility of offering psychedelics testing among other services. CSO Sharan Sidhu explained: we can now develop and implement standardized…

Source

Previous articlePharmaDrug Announces World-Renowned Gastric Cancer Expert Dr. Yelena Y. Janjigian Joins Sairiyo Therapeutics Scientific and Clinical Advisory Board
Next articleSilo Pharma, Inc. Enters into an Exclusive Option Agreement with the University of Maryland, Baltimore for patented Homing Peptides Targeting Rheumatoid Arthritis